Friday June 26 2020
in todays report:
click here for video on yt
Oral THC Effective in Mitigating Agitation Due to Alzheimer’s Austrian psychiatrists found that a patient was able to
reduce her usage of several pharmaceutical medications for Alzheimer's after using dronabinol, a synthetic form of THC.
A new case report by Austrian psychiatrists suggests that dronabinol, a synthetic form of THC, may be a more effective
treatment for Alzheimer's-induced dementia than traditional pharmaceutical medications.
https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00413/full
Cannabinoid as Beneficial Replacement Therapy for Psychotropics
to Treat Neuropsychiatric Symptoms in Severe
Alzheimer’s Dementia: A Clinical Case Report Similarly, the use of
first-generation antipsychotics is associated with a
significant risk for adverse events and increased mortality rates (9).
As a consequence, regulatory agencies and most
guidelines have advised against the use of antipsychotic drugs in
patients with AD (10). Alternative pharmacological
treatment options are therefore urgently needed. A small number
of clinical trials and several case reports have shown
that cannabinoids such as oral dronabinol (Δ9- . To date, cannabinoid
receptor agonists are commonly used to treat
nausea, anorexia, pain, and anxiety in oncological patients and in those
with severe spasticity. Serious side effects such
as marked orthostatic hypotension or psychotic symptoms are rare,
however, metabolization of THC by liver
cytochromes P450 can cause considerable drug-interactions. further
investigations addressing the therapeutic potential of THC in patients
with AD in clinical studies and pharmacological models are urgently needed.
Prior studies reported that especially lower doses of THC may have anxiolytic
effects (17, 18). Further, our findings corroborate those of Herrmann et al. who
reported on a positive effect of the cannabinoid nabilone—a synthetic oral THC
analog—on agitation in patients with AD (19). Our report underpins the need for
randomized, controlled trials to explore the effect of cannabinoid receptor agonists
on behavioral and psychological
symptoms in patients in different stages of AD
https://en.m.wikipedia.org/wiki/Dronabinol
WASHINGTON, D.C. – The Pentagon has moved to make use of CBD
products a criminal offense for troops across all branches of the U.S.
military, according to reports from military news websites. WASHINGTON,
D.C. – The Pentagon has moved to make use of CBD products a criminal
offense for troops across all branches of the U.S. military, according to
reports from military news websites. Donovan stated: “Substance misuse
by service members is a safety and readiness issue, and the Department
must remain vigilant in addressing emerging threats, including those that
come from new products and sources.” Donovan said an overall policy was
required to “protect the integrity of the drug testing program.” Donovan said
an overall policy was required to “protect the integrity of the drug testing program.”
https://fionabarnett.org/2020/06/13/mk-ultra-in-the-military/ https://mgretailer.com/cannabis-news/cbd-product-use-a-crime-punishable-under-military-code-says-pentagon/
Canadian Cannabis Retailers Union Announces Focus on Education and Training
TORONTO – The Canadian Cannabis Retailers Union Inc. (CCRU) today announced that effective today, it has ceased its cannabis retailer membership operations.
This strategic shift will allow the CCRU to focus exclusively on the growing opportunity to provide its cannabis retail training program to bud-tenders and store managers and owners across the country.
https://harrisbricken.com/cannalawblog/cannabis-competition-and-a-constitutional-crisis/